1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Esophagitis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Esophagitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biancani, P; Falk, GW; Harnett, K; Rieder, F; Yerian, L	1
Leung, JW; Mann, NS	1
Behar, J; Biancani, P; Cao, W; Cheng, L; Fiocchi, C; Harnett, KM	2

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Esophagitis

Article	Year
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:5 Topics: Animals; Endothelial Cells; Esophageal Motility Disorders; Esophageal Neoplasms; Esophagitis; Esophagogastric Junction; Fibrosis; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Inflammation Mediators; Interleukin-1; Interleukin-6; Interleukin-8; Mesoderm; Platelet Activating Factor; Reactive Oxygen Species	2010

Article

Year

Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:5

Topics: Animals; Endothelial Cells; Esophageal Motility Disorders; Esophageal Neoplasms; Esophagitis; Esophagogastric Junction; Fibrosis; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Inflammation Mediators; Interleukin-1; Interleukin-6; Interleukin-8; Mesoderm; Platelet Activating Factor; Reactive Oxygen Species

2010

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Esophagitis

Article	Year
Pathogenesis of esophageal rings in eosinophilic esophagitis. Medical hypotheses, 2005, Volume: 64, Issue:3 Topics: Acetylcholine; Adult; Allergens; Antimicrobial Cationic Peptides; Chemotactic Factors; Eosinophilia; Eosinophils; Esophagitis; Esophagus; Gastroenteritis; Histamine; Humans; Intestinal Mucosa; Mast Cells; Muscle Contraction; Muscle Fibers, Skeletal; Platelet Activating Factor	2005
Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. American journal of physiology. Gastrointestinal and liver physiology, 2005, Volume: 289, Issue:3 Topics: Acetylcholine; Animals; Cats; Dinoprostone; Esophagitis; Esophagus; Inflammation; Interleukin-1; Interleukin-6; Male; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Reactive Oxygen Species	2005
Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1 Topics: Electric Stimulation; Esophagitis; Esophagus; Humans; Hydrochloric Acid; Hydrogen Peroxide; In Vitro Techniques; Inflammation Mediators; Interleukin-1; Interleukin-6; Mucous Membrane; Muscle Contraction; Muscle, Smooth; NADPH Oxidases; Platelet Activating Factor	2006